CMR Surgical Inc.

CMR Surgical Ltd develops and manufactures the Versius Plus robotic-assisted surgical system, a compact, modular platform designed for minimally invasive surgery. The Versius Plus is FDA 510(k) cleared for cholecystectomy and represents the second most utilized robotic surgical platform globally, with over 45,000 cases performed worldwide. The system features a modular design requiring no dedicated operating room, enabling flexible port placement and seamless switching between robotic and non-robotic procedures. Key technological components include vLimeLite, an integrated fluorescence visualization system with indocyanine green (ICG) imaging capability, multiple visualization modes, and a 26-inch 3DHD display. The platform integrates a full suite of fully articulated surgical instruments with both electrosurgical and non-electrosurgical capabilities. CMR Surgical's ecosystem includes software-driven features such as Versius Connect (surgeon procedural logbook) and Versius Team (hospital dashboard for usage tracking, case volume, and system efficiency monitoring). The company operates globally with headquarters in Cambridge, UK, and regional offices across India, Italy, Brazil, Germany, Poland, France, and Spain. Manufacturing and R&D operations are based in the UK with additional technology and operations facilities in Ely. The company has secured significant funding exceeding $200 million to accelerate US market expansion and product development.